- Home
- IRON vs BFC Comparison
IRON vs BFC Comparison
Compare IRON & BFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRON
- BFC
- Stock Information
- Founded
- IRON 2017
- BFC 1894
- Country
- IRON United States
- BFC United States
- Employees
- IRON N/A
- BFC N/A
- Industry
- IRON Biotechnology: Pharmaceutical Preparations
- BFC Major Banks
- Sector
- IRON Health Care
- BFC Finance
- Exchange
- IRON Nasdaq
- BFC Nasdaq
- Market Cap
- IRON 1.4B
- BFC 1.1B
- IPO Year
- IRON N/A
- BFC N/A
- Fundamental
- Price
- IRON $51.61
- BFC $110.95
- Analyst Decision
- IRON Strong Buy
- BFC Buy
- Analyst Count
- IRON 10
- BFC 2
- Target Price
- IRON $93.40
- BFC $111.00
- AVG Volume (30 Days)
- IRON 372.4K
- BFC 104.9K
- Earning Date
- IRON 08-07-2025
- BFC 07-15-2025
- Dividend Yield
- IRON N/A
- BFC 4.74%
- EPS Growth
- IRON N/A
- BFC N/A
- EPS
- IRON N/A
- BFC 6.81
- Revenue
- IRON N/A
- BFC $163,459,000.00
- Revenue This Year
- IRON N/A
- BFC $12.55
- Revenue Next Year
- IRON N/A
- BFC $5.79
- P/E Ratio
- IRON N/A
- BFC $16.26
- Revenue Growth
- IRON N/A
- BFC N/A
- 52 Week Low
- IRON $30.82
- BFC $77.00
- 52 Week High
- IRON $68.73
- BFC $119.04
- Technical
- Relative Strength Index (RSI)
- IRON 56.99
- BFC 41.01
- Support Level
- IRON $48.87
- BFC $109.11
- Resistance Level
- IRON $54.13
- BFC $117.34
- Average True Range (ATR)
- IRON 2.31
- BFC 2.44
- MACD
- IRON 0.07
- BFC -0.74
- Stochastic Oscillator
- IRON 67.64
- BFC 22.36
About IRON Disc Medicine Inc.
Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.
About BFC Bank First Corporation
Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.